Advances in Immunotherapy for Transplant Oncology
Cancers · 28.06.2024 · 16 (13) · 2369
DOI: 10.3390/cancers16132369 ↗Kurz gefasst
Editorial in der Zeitschrift Cancers, online erschienen am 28.06.2024. Verfasst von Maen Abdelrahim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of GI Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The increasing incidence of global cancer rates has created an entirely new demand for curative treatment modalities to improve patient outcomes [...]
Autor:innen und Institutionen
- Section of GI Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA.
- Gastrointestinal Medical Oncology, Georgetown University Hospital, Washington, DC 20007, USA.
- Division of Oncology, Washington University, St. Louis, MO 63110, USA.
- Department of Gastroenterology & Hepatology, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan.
ORCID-Profile: Abdullah Esmail, Moh'd Khushman, Yaser Rayyan
Förderung
- NCI NIH HHS
Zitieren
APA
Abdelrahim, M., Esmail, A., He, A. R., Khushman, M., & Rayyan, Y. (2024). Advances in Immunotherapy for Transplant Oncology. Cancers, 16(13), 2369. https://doi.org/10.3390/cancers16132369
Vancouver
Abdelrahim M, Esmail A, He AR, Khushman M, Rayyan Y. Advances in Immunotherapy for Transplant Oncology. Cancers. 2024;16(13):2369. doi:10.3390/cancers16132369
BibTeX
@article{Abdelrahim2024,
author = {Abdelrahim, Maen and Esmail, Abdullah and He, Aiwu Ruth and Khushman, Moh'd and Rayyan, Yaser},
title = {Advances in Immunotherapy for Transplant Oncology},
journal = {Cancers},
year = {2024},
volume = {16},
number = {13},
pages = {2369},
doi = {10.3390/cancers16132369}
}
EUVIMED